When we hear about using AI in drug discovery, we tend to imagine the stage where it "thinks up new molecules."However, ...

Fundamentals, Assays and Industrial Implications of Target-Binding Characterisation for Recombinant Proteins HUSTON, ...

Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE)-- "mRNA Drug Discovery and Manufacturing Platforms Market - Strategic Insights and Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.

The U.S. Department of Energy’s (DOE) Argonne National Laboratory is joining DOE’s Pacific Northwest National Laboratory ...

MARVEL-AI accelerates materials innovation by combining AI, automation and advanced research from discovery to deployment.

It is easy to get the impression that once AI finds a new drug candidate, it can be used for treatment immediately.However, ...

Anthropic’s Claude AI has successfully generated 35,000 antibody designs for potential allergy treatments, demonstrating ...

Accelerator, led by the U.S. Department of Energy’s Pacific Northwest National Laboratory (PNNL), will bring together national laboratories, universities, and industry partners to address critical ...

Series B funding will strengthen Multiply Labs' momentum scaling the robotic manufacturing platform turning AI-discovered drugs into treatments patients can receive. Multiply Labs, the physical AI ...

Between October 13 and October 19, 2026, China’s Ministry of Commerce (MOFCOM), jointly with several additional agencies, released a package of ...

Multiply Labs, the physical AI company automating some of the most complex manufacturing processes in medicine, today announced a $75 million Series B, bringing its total capital raised to over $100 ...